Sperling Prostate Center

Understanding the “Watchful Waiting” Approach in Prostate Cancer Treatment

The American Cancer Society estimated that about 1 in every 6 males will be diagnosed with prostate cancer in their lifetimes. Here at our prostate cancer treatment practice, surgery is not recommended right away. Dr. Sperling offers several methods to treat prostate tumors minus the surgical approach.

Active Surveillance in Prostate Cancer Treatment

One of the key components of choosing the road less taken when it comes to prostate cancer treatment is the “active surveillance” approach. Also known as the “delayed intervention” approach, newly-diagnosed patients are recommended to undergo lifestyle changes and continuous monitoring of cancer progression.

This Medical News Today article pointed out that prostate cancer researchers are now encouraging the watchful waiting approach rather than choose aggressive treatment methods. Such approach according to the head researchers could help prevent the decline in the quality of life which is common among those who chose to have surgery.

In addition, this 15 year-old study published in the New England Journal of Medicine comparing radical prostatectomy versus the watchful waiting approach found out that men who had early-stage prostate cancer who chose the latter are just as likely to survive than those underwent surgery.

Prostate Cancer Detection and Treatment in Florida

Dan Sperling, MD is a premier authority and pioneer in the use of MRI-Guided prostate imaging. His groundbreaking work at The Sperling Prostate Center represents a new paradigm in both the detection and treatment of prostate cancer. Call us now at 877-605-2737 or fill out this contact form to request a consultation. We look forward to helping you get the most suitable treatment following your diagnosis of prostate cancer.

About Dr. Dan Sperling

Dan Sperling, MD, DABR, is a board certified radiologist who is globally recognized as a leader in multiparametric MRI for the detection and diagnosis of a range of disease conditions. As Medical Director of the Sperling Prostate Center, Sperling Medical Group and Sperling Neurosurgery Associates, he and his team are on the leading edge of significant change in medical practice. He is the co-author of the new patient book Redefining Prostate Cancer, and is a contributing author on over 25 published studies. For more information, contact the Sperling Prostate Center.

WordPress Image Lightbox